In the gut of patients with heart failure, important groups of bacteria are found less frequently and the gut flora is not as diverse as in healthy individuals. [ + ]

Australian medical device company Oventus Medical has received FDA 510k clearance for its O₂Vent W device. [ + ]

Exceptional researchers in the fields of infectious disease, autoimmunity, chronic pain and Parkinson's disease are among the Australians honoured with National Health and Medical Research Council (NHMRC) Research Excellence Awards. [ + ]

University of Queensland researchers have discovered that switching off a protein produced in breast cancer cells can stop cancer progression. [ + ]

The Australian Government has signed a 10-year strategic partnership with the European Southern Observatory (ESO). [ + ]

Medicinal cannabis start-up LeafCann Research and Advisory has appointed Dr Elise Sullivan as its director of clinical education. [ + ]

Life sciences company Thermo Fisher Scientific and research centre SRI International have announced a collaboration to enhance small molecule research.  [ + ]

University of Technology Sydney scientist and Associate Professor Cynthia Whitchurch has become the first female scientist to win the David Syme Research Prize in over 30 years. [ + ]

Each year around 78 million people are infected with gonorrhoea, a common sexually transmitted infection. [ + ]

Illumina has announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit. [ + ]

A Victorian government-commissioned study has confirmed that the eradication of an established pest species can be extremely resource-intensive and costly, and recommends investment in novel tools such as innovative monitoring techniques and improved prevention strategies. [ + ]

Adelaide-based start-up Micro-X has announced that its DRX Revolution Nano, a lightweight X-ray machine for mobile radiography, has received Food and Drug Administration (FDA) approval. [ + ]

Monash University scientists have published the results of their study into mesenchymal stem cells (MSCs) from Cynata Therapeutics, revealing that the company's technology holds promise as a treatment for chronic asthma. [ + ]

A personal cancer treatment vaccine that targets distinctive 'neoantigens' on tumour cells has been shown to stimulate a potent, safe and highly specific immune anti-tumour response in melanoma patients, reported scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. [ + ]

The life sciences industry has welcomed the restoration of key occupations for the medical technology, biotechnology, research and pharmaceutical sector to the skilled migration visa list. [ + ]